Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer.

Clinical genitourinary cancer

Poole A, Gill D, Hahn AW, Johnson E, Carroll E, Boucher K, Nussenzveig R, Maughan B, Agarwal N.
PMID: 28958675
Clin Genitourin Cancer. 2017 Sep 06; doi: 10.1016/j.clgc.2017.08.017. Epub 2017 Sep 06.

BACKGROUND: Antiandrogen withdrawal syndrome (AAWS), manifested as a prostate-specific antigen (PSA) decline after discontinuation of a first-generation antiandrogen has been well characterized. The objective of the present study was to assess the incidence of AAWS with enzalutamide in men...

Cite
Poole A, Gill D, Hahn AW, et al. Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017;doi: 10.1016/j.clgc.2017.08.017.
Poole, A., Gill, D., Hahn, A. W., Johnson, E., Carroll, E., Boucher, K., Nussenzveig, R., Maughan, B., & Agarwal, N. (2017). Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer. Clinical genitourinary cancer, . https://doi.org/10.1016/j.clgc.2017.08.017
Poole, Austin, et al. "Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer." Clinical genitourinary cancer vol. (2017). doi: https://doi.org/10.1016/j.clgc.2017.08.017
Poole A, Gill D, Hahn AW, Johnson E, Carroll E, Boucher K, Nussenzveig R, Maughan B, Agarwal N. Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 Sep 06; doi: 10.1016/j.clgc.2017.08.017. Epub 2017 Sep 06. PMID: 28958675.
Copy Download .nbib Format: NLM
Negative optical torque on a microsphere in optical tweezers.

Optics express

Diniz K, Dutra RS, Pires LB, Viana NB, Nussenzveig HM, Maia Neto PA.
PMID: 30876186
Opt Express. 2019 Mar 04;27(5):5905-5917. doi: 10.1364/OE.27.005905.

We show that the optical force field in optical tweezers with elliptically polarized beams has the opposite handedness for a wide range of particle sizes and for the most common configurations. Our method is based on the direct observation...

Cite
Diniz K, Dutra RS, Pires LB, et al. Negative optical torque on a microsphere in optical tweezers. Opt Express. 2019;27(5):5905-5917doi: 10.1364/OE.27.005905.
Diniz, K., Dutra, R. S., Pires, L. B., Viana, N. B., Nussenzveig, H. M., & Maia Neto, P. A. (2019). Negative optical torque on a microsphere in optical tweezers. Optics express, 27(5), 5905-5917. https://doi.org/10.1364/OE.27.005905
Diniz, K, et al. "Negative optical torque on a microsphere in optical tweezers." Optics express vol. 27,5 (2019): 5905-5917. doi: https://doi.org/10.1364/OE.27.005905
Diniz K, Dutra RS, Pires LB, Viana NB, Nussenzveig HM, Maia Neto PA. Negative optical torque on a microsphere in optical tweezers. Opt Express. 2019 Mar 04;27(5):5905-5917. doi: 10.1364/OE.27.005905. PMID: 30876186.
Copy Download .nbib Format: NLM
Third-order nonlinearity OPO: Schmidt mode decomposition and tripartite entanglement.

Optics letters

González-Arciniegas C, Treps N, Nussenzveig P.
PMID: 29216130
Opt Lett. 2017 Dec 01;42(23):4865-4868. doi: 10.1364/OL.42.004865.

We investigate quantum properties of light in optical parametric oscillators (OPOs) based on four-wave mixing gain in media with third-order nonlinearities. In spite of other competing χ

Cite
González-Arciniegas C, Treps N, Nussenzveig P. Third-order nonlinearity OPO: Schmidt mode decomposition and tripartite entanglement. Opt Lett. 2017;42(23):4865-4868doi: 10.1364/OL.42.004865.
González-Arciniegas, C., Treps, N., & Nussenzveig, P. (2017). Third-order nonlinearity OPO: Schmidt mode decomposition and tripartite entanglement. Optics letters, 42(23), 4865-4868. https://doi.org/10.1364/OL.42.004865
González-Arciniegas, C, et al. "Third-order nonlinearity OPO: Schmidt mode decomposition and tripartite entanglement." Optics letters vol. 42,23 (2017): 4865-4868. doi: https://doi.org/10.1364/OL.42.004865
González-Arciniegas C, Treps N, Nussenzveig P. Third-order nonlinearity OPO: Schmidt mode decomposition and tripartite entanglement. Opt Lett. 2017 Dec 01;42(23):4865-4868. doi: 10.1364/OL.42.004865. PMID: 29216130.
Copy Download .nbib Format: NLM
Comprehensive Analysis of .

The oncologist

Ledet EM, Lilly MB, Sonpavde G, Lin E, Nussenzveig RH, Barata PC, Yandell M, Nagy RJ, Kiedrowski L, Agarwal N, Sartor O.
PMID: 31712304
Oncologist. 2019 Nov 11; doi: 10.1634/theoncologist.2019-0115. Epub 2019 Nov 11.

BACKGROUND: Somatic alterations in circulating tumor DNA (ctDNA) may be associated with treatment response or prognosis in prostate cancer (PCa). The goal was to characterize androgen receptor gene (PATIENTS AND METHODS: This study included a heterogeneous group of 892...

Cite
Ledet EM, Lilly MB, Sonpavde G, et al. Comprehensive Analysis of . Oncologist. 2019;doi: 10.1634/theoncologist.2019-0115.
Ledet, E. M., Lilly, M. B., Sonpavde, G., Lin, E., Nussenzveig, R. H., Barata, P. C., Yandell, M., Nagy, R. J., Kiedrowski, L., Agarwal, N., & Sartor, O. (2019). Comprehensive Analysis of . The oncologist, . https://doi.org/10.1634/theoncologist.2019-0115
Ledet, Elisa M, et al. "Comprehensive Analysis of ." The oncologist vol. (2019). doi: https://doi.org/10.1634/theoncologist.2019-0115
Ledet EM, Lilly MB, Sonpavde G, Lin E, Nussenzveig RH, Barata PC, Yandell M, Nagy RJ, Kiedrowski L, Agarwal N, Sartor O. Comprehensive Analysis of . Oncologist. 2019 Nov 11; doi: 10.1634/theoncologist.2019-0115. Epub 2019 Nov 11. PMID: 31712304.
Copy Download .nbib Format: NLM
Quantum interference between transverse spatial waveguide modes.

Nature communications

Mohanty A, Zhang M, Dutt A, Ramelow S, Nussenzveig P, Lipson M.
PMID: 28106036
Nat Commun. 2017 Jan 20;8:14010. doi: 10.1038/ncomms14010.

Integrated quantum optics has the potential to markedly reduce the footprint and resource requirements of quantum information processing systems, but its practical implementation demands broader utilization of the available degrees of freedom within the optical field. To date, integrated...

Cite
Mohanty A, Zhang M, Dutt A, et al. Quantum interference between transverse spatial waveguide modes. Nat Commun. 2017;8:14010doi: 10.1038/ncomms14010.
Mohanty, A., Zhang, M., Dutt, A., Ramelow, S., Nussenzveig, P., & Lipson, M. (2017). Quantum interference between transverse spatial waveguide modes. Nature communications, 814010. https://doi.org/10.1038/ncomms14010
Mohanty, Aseema, et al. "Quantum interference between transverse spatial waveguide modes." Nature communications vol. 8 (2017): 14010. doi: https://doi.org/10.1038/ncomms14010
Mohanty A, Zhang M, Dutt A, Ramelow S, Nussenzveig P, Lipson M. Quantum interference between transverse spatial waveguide modes. Nat Commun. 2017 Jan 20;8:14010. doi: 10.1038/ncomms14010. PMID: 28106036; PMCID: PMC5263888.
Copy Download .nbib Format: NLM
Direct production of tripartite pump-signal-idler entanglement in the above-threshold optical parametric oscillator.

Physical review letters

Villar AS, Martinelli M, Fabre C, Nussenzveig P.
PMID: 17155232
Phys Rev Lett. 2006 Oct 06;97(14):140504. doi: 10.1103/PhysRevLett.97.140504. Epub 2006 Oct 06.

We calculate the quantum correlations existing among the three output fields (pump, signal, and idler) of a triply resonant nondegenerate optical parametric oscillator operating above threshold. By applying the standard criteria [P. van Loock and A. Furusawa, Phys. Rev....

Cite
Villar AS, Martinelli M, Fabre C, et al. Direct production of tripartite pump-signal-idler entanglement in the above-threshold optical parametric oscillator. Phys Rev Lett. 2006;97(14):140504doi: 10.1103/PhysRevLett.97.140504.
Villar, A. S., Martinelli, M., Fabre, C., & Nussenzveig, P. (2006). Direct production of tripartite pump-signal-idler entanglement in the above-threshold optical parametric oscillator. Physical review letters, 97(14), 140504. https://doi.org/10.1103/PhysRevLett.97.140504
Villar, A S, et al. "Direct production of tripartite pump-signal-idler entanglement in the above-threshold optical parametric oscillator." Physical review letters vol. 97,14 (2006): 140504. doi: https://doi.org/10.1103/PhysRevLett.97.140504
Villar AS, Martinelli M, Fabre C, Nussenzveig P. Direct production of tripartite pump-signal-idler entanglement in the above-threshold optical parametric oscillator. Phys Rev Lett. 2006 Oct 06;97(14):140504. doi: 10.1103/PhysRevLett.97.140504. Epub 2006 Oct 06. PMID: 17155232.
Copy Download .nbib Format: NLM
Diffraction as tunneling.

Physical review letters

Nussenzveig HM, Wiscombe WJ.
PMID: 10035298
Phys Rev Lett. 1987 Oct 12;59(15):1667-1670. doi: 10.1103/PhysRevLett.59.1667.

No abstract available.

Cite
Nussenzveig HM, Wiscombe WJ. Diffraction as tunneling. Phys Rev Lett. 1987;59(15):1667-1670doi: 10.1103/PhysRevLett.59.1667.
Nussenzveig, H. M., & Wiscombe, W. J. (1987). Diffraction as tunneling. Physical review letters, 59(15), 1667-1670. https://doi.org/10.1103/PhysRevLett.59.1667
Nussenzveig, and Wiscombe. "Diffraction as tunneling." Physical review letters vol. 59,15 (1987): 1667-1670. doi: https://doi.org/10.1103/PhysRevLett.59.1667
Nussenzveig HM, Wiscombe WJ. Diffraction as tunneling. Phys Rev Lett. 1987 Oct 12;59(15):1667-1670. doi: 10.1103/PhysRevLett.59.1667. PMID: 10035298.
Copy Download .nbib Format: NLM
Complex angular momentum approximation to hard-core scattering.

Physical review. A, Atomic, molecular, and optical physics

Nussenzveig HM, Wiscombe WJ.
PMID: 9905259
Phys Rev A. 1991 Mar 01;43(5):2093-2112. doi: 10.1103/physreva.43.2093.

No abstract available.

Cite
Nussenzveig HM, Wiscombe WJ. Complex angular momentum approximation to hard-core scattering. Phys Rev A. 1991;43(5):2093-2112doi: 10.1103/physreva.43.2093.
Nussenzveig, H. M., & Wiscombe, W. J. (1991). Complex angular momentum approximation to hard-core scattering. Physical review. A, Atomic, molecular, and optical physics, 43(5), 2093-2112. https://doi.org/10.1103/physreva.43.2093
Nussenzveig, and Wiscombe. "Complex angular momentum approximation to hard-core scattering." Physical review. A, Atomic, molecular, and optical physics vol. 43,5 (1991): 2093-2112. doi: https://doi.org/10.1103/physreva.43.2093
Nussenzveig HM, Wiscombe WJ. Complex angular momentum approximation to hard-core scattering. Phys Rev A. 1991 Mar 01;43(5):2093-2112. doi: 10.1103/physreva.43.2093. PMID: 9905259.
Copy Download .nbib Format: NLM
Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?.

Annals of oncology : official journal of the European Society for Medical Oncology

Hahn AW, Nussenzveig RH, Pal SK, Agarwal N.
PMID: 28945831
Ann Oncol. 2017 Oct 01;28(10):2333-2335. doi: 10.1093/annonc/mdx418.

No abstract available.

Cite
Hahn AW, Nussenzveig RH, Pal SK, et al. Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?. Ann Oncol. 2017;28(10):2333-2335doi: 10.1093/annonc/mdx418.
Hahn, A. W., Nussenzveig, R. H., Pal, S. K., & Agarwal, N. (2017). Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?. Annals of oncology : official journal of the European Society for Medical Oncology, 28(10), 2333-2335. https://doi.org/10.1093/annonc/mdx418
Hahn, A W, et al. "Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?." Annals of oncology : official journal of the European Society for Medical Oncology vol. 28,10 (2017): 2333-2335. doi: https://doi.org/10.1093/annonc/mdx418
Hahn AW, Nussenzveig RH, Pal SK, Agarwal N. Blood- and tissue-based tumor genomics: a battle royale or match made in heaven?. Ann Oncol. 2017 Oct 01;28(10):2333-2335. doi: 10.1093/annonc/mdx418. PMID: 28945831.
Copy Download .nbib Format: NLM
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

The oncologist

Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N.
PMID: 34423501
Oncologist. 2021 Dec;26(12):1006-e2129. doi: 10.1002/onco.13949. Epub 2021 Sep 23.

LESSONS LEARNED: Long-term safety of radium-223 with enzalutamide was confirmed in this clinical trial. PSA-PFS2 was prolonged with the combination compared with enzalutamide alone.BACKGROUND: Previously, we showed the combination of radium-223 and enzalutamide to be safe and associated with...

Cite
Maughan BL, Kessel A, McFarland TR, et al. Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. Oncologist. 2021;26(12):1006-e2129doi: 10.1002/onco.13949.
Maughan, B. L., Kessel, A., McFarland, T. R., Sayegh, N., Nussenzveig, R., Hahn, A. W., Hoffman, J. M., Morton, K., Sirohi, D., Kohli, M., Swami, U., Boucher, K., Haaland, B., & Agarwal, N. (2021). Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. The oncologist, 26(12), 1006-e2129. https://doi.org/10.1002/onco.13949
Maughan, Benjamin L, et al. "Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results." The oncologist vol. 26,12 (2021): 1006-e2129. doi: https://doi.org/10.1002/onco.13949
Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N. Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. Oncologist. 2021 Dec;26(12):1006-e2129. doi: 10.1002/onco.13949. Epub 2021 Sep 23. PMID: 34423501.
Copy Download .nbib Format: NLM
Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis.

The American Journal of dermatopathology

Heibel HD, Ibad S, Chao Y, Patel KK, Hutto J, Redd LE, Nussenzveig DR, Laborde KH, Cockerell CJ, Shwin K.
PMID: 34086641
Am J Dermatopathol. 2021 Dec 01;43(12):e230-e233. doi: 10.1097/DAD.0000000000001993.

ABSTRACT: Leukocytoclastic vasculitis (LCV) is a small vessel inflammatory condition considered to be caused by circulating immune complexes and often occurs after an acute infection or exposure to a new medication, although it may be associated with an underlying...

Cite
Heibel HD, Ibad S, Chao Y, et al. Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis. Am J Dermatopathol. 2021;43(12):e230-e233doi: 10.1097/DAD.0000000000001993.
Heibel, H. D., Ibad, S., Chao, Y., Patel, K. K., Hutto, J., Redd, L. E., Nussenzveig, D. R., Laborde, K. H., Cockerell, C. J., & Shwin, K. (2021). Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis. The American Journal of dermatopathology, 43(12), e230-e233. https://doi.org/10.1097/DAD.0000000000001993
Heibel, Haley D, et al. "Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis." The American Journal of dermatopathology vol. 43,12 (2021): e230-e233. doi: https://doi.org/10.1097/DAD.0000000000001993
Heibel HD, Ibad S, Chao Y, Patel KK, Hutto J, Redd LE, Nussenzveig DR, Laborde KH, Cockerell CJ, Shwin K. Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis. Am J Dermatopathol. 2021 Dec 01;43(12):e230-e233. doi: 10.1097/DAD.0000000000001993. PMID: 34086641.
Copy Download .nbib Format: NLM
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

The oncologist

Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N.
PMID: 34423501
Oncologist. 2021 Dec;26(12):1006-e2129. doi: 10.1002/onco.13949. Epub 2021 Sep 23.

LESSONS LEARNED: Long-term safety of radium-223 with enzalutamide was confirmed in this clinical trial. PSA-PFS2 was prolonged with the combination compared with enzalutamide alone.BACKGROUND: Previously, we showed the combination of radium-223 and enzalutamide to be safe and associated with...

Cite
Maughan BL, Kessel A, McFarland TR, et al. Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. Oncologist. 2021;26(12):1006-e2129doi: 10.1002/onco.13949.
Maughan, B. L., Kessel, A., McFarland, T. R., Sayegh, N., Nussenzveig, R., Hahn, A. W., Hoffman, J. M., Morton, K., Sirohi, D., Kohli, M., Swami, U., Boucher, K., Haaland, B., & Agarwal, N. (2021). Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. The oncologist, 26(12), 1006-e2129. https://doi.org/10.1002/onco.13949
Maughan, Benjamin L, et al. "Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results." The oncologist vol. 26,12 (2021): 1006-e2129. doi: https://doi.org/10.1002/onco.13949
Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N. Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results. Oncologist. 2021 Dec;26(12):1006-e2129. doi: 10.1002/onco.13949. Epub 2021 Sep 23. PMID: 34423501; PMCID: PMC8649019.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries